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Background: Little is known about the prevalence and impact of cognitive impairment in polypathological
patients (PPs).
Objectives: To assess the prevalence of cognitive impairment (CI) and delirium, their associated risk
factors, and their impact on survival of a multicenter population of PPs.
Methods: Prospective cohort study. Descriptive analysis of the prevalence, main clinical features of PPs
with basal CI (by means of Short Portable Mental Status Questionnaire), and delirium (Confusion
Assessment Method); and bivariate as well as multivariate assessment of the factors associated with both
conditions. Survival analysis after 12 months follow-up by means of KaplaneMeier curves, and multi-
variate analysis of mortality risk factors in PPs with CI, and those with delirium.
Results: CI was present in 39% [28% mild to moderate (3e7 errors), and 11% severe ( 8 errors)] of the
1434 PPs assessed [in the remaining 11% (n¼ 198) delirium was detected]; only 26% of them had been
previously diagnosed with dementia. One-year mortality was 46%/31.4% in those with/without CI
[p< 0.0001; relative risk (RR)¼ 1.8 (1.5e2.3)]. Mean survival was 305 4/266 5 days in those with/
without CI (p< 0.0001). One-year mortality was 54.5%/34.8% in PPs with/without delirium, [p< 0.0001,
RR¼ 2.25 (1.65e3)]. Mean survival after inclusion was 296 4/241 10 days in those with/without
delirium (P< 0.0001). Factors independently associated with mortality in PPs with CI were the presence
of a concomitant active neoplasm [p¼ 0.007; RR¼ 3 (1.3e6.7)], severe dyspnea (p¼ 0.04; RR¼ 1.6 (1.02
e2.6)], higher comorbidity load (p¼ 0.003; RR¼ 1.2 (1.07e1.4)], and  4 hospital admissions in the
previous 12 months [p< 0.0001; RR¼ 5.2 (2.4e11.5)]. Factors associated with mortality in PPs with
delirium were age  85 years [p¼ 0.021, RR¼ 2.3 (1.14e4.6)], chronic liver disease (p¼ 0.019, RR¼ 5.9
(1.3e25)], severe dyspnea [p¼ 0.007; RR¼ 2.7 (1.3e5.4)], plasma creatinine levels > 2 mg/dL [p¼ 0.003;
RR¼ 7.8 (2e26)], and polypharmacy [p¼ 0.0019; RR¼ 3.1 (1.2e8.1)].
Conclusion: CI, as well as delirium, is common in PPs. Both play a deleterious role in 12-month survival. A
systematic cognitive assessment as well as prevention and early detection of delirium should be included
in the clinical care of all PPs.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
In spite of the growing prevalence of polypathological patients
(PPs) in all hospital wards, data concerning the impact and main
features of cognitive impairment (CI) in this population are scarce1.erest.
to this work.
Hospital Universitario Virgen
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l).
iwan Society of Geriatric EmergenPreliminary studies in individual primary care centers showed
a 37.75% prevalence of CI (moderateesevere in > 50% of the cases)
in PPs, whereas its prevalence in hospitalized PPs is not well
known2. A single study of 117 elderly PPs who were hospitalized in
a medium- to long-term facility detected mild, moderate, and
severe CI in 13%, 12%, and 31% of the patients, respectively3.
The impact of CI has been well studied in geriatric populations
in different settings4e6. One of the key factors contributing to the
clinical relevance of CI is its identiﬁcation as an early indicator of
dementia and/or a marker of undetected dementia4. The estimated
prevalence of CI in elderly populations is variable, between 2.5% andcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Impact of Cognitive Impairment in Polypathological Patients 8541% depending on the moment and/or criteria applied. Once CI is
established, progression to dementia occurs in 3.7e30% of patients4.
The identiﬁcation of CI is usually carried out with Pfeiffer’s Short
Portable Mental Status Questionnaire (SPMSQ) because of its high
sensitivity and speciﬁcity (> 90%). The SPMSQ has been already
validated in Spanish populations aged > 65 years7,8.
The relationship between age, comorbidity and CI is narrow and
reciprocal. Age is a well recognized factor in the development of CI,
and in the exposure to polypharmacy. In patients with CI, the asso-
ciated comorbidities constitute independent prognostic factors9.
Finally, many chronic diseases and cardiovascular-associated condi-
tions are treated with drugs, which potentially affect cognition, and
predispose to CI10. Nevertheless, the prognostic impact of CI in PPs is
not yet well established.
The cognitive problems of aged and multimorbid patients are
even more increased in hospital environments because of the
frequent concurrence of incidental delirium. Although delirium is
in most cases temporary, it can last for several months and may
have a poor evolution and prognosis in terms of functionality,
institutionalization and even death rates11,12. Its economic impact is
also high, with the expenses being comparable to those of diabetes
and falls in elderly people13. Although it is known that one in every
ﬁve hospitalized patients suffers from delirium, its real prevalence
and prognostic impact in PPs with recent hospital admissions is
unknown.
The present study was carried out for all of the above-mentioned
reasons, with the aim of determining the prevalence, clinical
characteristics, associated factors, and prognostic impact after 12
months follow-up of basal CI and delirium in a multicenter
hospital-based population of PPs.
2. Materials and methods
2.1. Study population
We studied PPs (using the 2007 deﬁnition) treated in 36 Spanish
hospitals from 11 Autonomous Communities. The eligible pop-
ulation corresponded to PPs living in the healthcare areas from
participating hospitals (listed along with the PROFUND Project
researchers at the end of this paper).
2.2. Type of study
This was a prospective, observational, multi-institutional study.
Patients were consecutively included between February 2007 and
June 2008, and followed during 12 months after inclusion.
2.3. Inclusion and exclusion criteria
The inclusion criteria were: (1) meeting established criteria for
PPs14; (2) being in one of the following medical care contexts:
hospital discharge, outpatient clinic follow-up, or at home hospi-
talization; and (3) acceptance in taking part in the study by signed
informed consent (either the patient and/or his/her legal repre-
sentative). Exclusion criteria were: (1) age < 18 years; and (2)
refusal of patient or relatives to participate in the study.
2.4. Development of study and variables
At inclusion, a complete data set of demographic, sociofamilial,
clinical, medical care, functional, and mental areas were recorded
as detailed: age; sex; profession; dwelling; need for a personal
caregiver and caregiver’s proﬁle; type, severity and number of PP
categories and other comorbidities; different symptoms and signs;
Charlson Index score; blood hemoglobin (g/dL), creatinine (mg/dL)and albumin (g/dL) levels; number of falls in the past year, number
and type of chronic drug prescriptions, number of hospital
admissions in the past year and past 3 months; performance of
activities of daily living (ADLs) and instrumental activities (IAs) by
means of Barthel Index (BI) as well as LawtoneBrody (LB) index,
respectively; cognitive status by means of SPMSQ (excluding
patients with delirium at the time of the inclusion interview), and
presence of delirium by means of Confusion Assessment Method
(CAM); and sociofamilial evaluation by means of the abbreviated
Gijón scale12,15e17. All patients were followed during 12 months, to
collect end-point variables (survival, and functional status in per-
forming ADLs by means of BI).
2.5. Deﬁnitions
The dyspnea functional class and severity of liver disease were
categorized by means of the New York Heart Association (NYHA)
class (in PPs with heart failure), Medical Research Council (MRC)
scale (in PPs with chronic respiratory failure), and ChildePugh scale
(in PPs with chronic liver failure)18e20. Dependence in functional
status for ADLs and IAs was deﬁned by a BI< 60 points and by an LB
score< 8 for women and< 5 for men, respectively. Cognitive status
was categorized as follows: 0e2 errors, no impairment; 3e4 errors,
mild impairment; 5e7 errors, moderate impairment; and 8e10
errors, severe impairment. Hence, CI was deﬁned by an SPMSQ
score of  3 errors ( 4 if they had not completed primary school
and  2 if they had an advanced degree). Delirium was deﬁned as
established by the CAM algorithm (acute onset and ﬂuctuating
course; plus presence of inattention; plus either disorganized
thinking, or altered level of consciousness).
2.6. Statistical analysis
A descriptive analysis of the clinical proﬁle of PPs with basal CI
and delirium during their last hospital admission was performed.
The possible factors independently associated with both of these
cognitive problems, as well as those associated with the end-points
after 12 months follow-up in these two populations of PPs, were
assessed.
The dichotomous variables were described as whole numbers
and percentages, and the continuous variables as means and
standard deviations [median and interquartile range (IQR) if the
distribution was not normal]. The distribution of each variable was
analyzed with the KolmogoroveSmirnov test.
An inferential bivariate analysis was carried out on the possible
predicting factors of basal CI and delirium, and those that could
predict 12-month mortality and functional decline, using the c2
test (Yates corrected, and when necessary, Fisher’s exact test),
Student’s t test, analysis of variance (TukeyeDunnett post hoc test)
for normally distributed variables, and the ManneWhitney U and
KruskaleWallis test for quantitative variables and variables that
were not normally distributed, respectively. The correlations
between two continuous variables were analyzed with Pearson’s
test. Differences were quantiﬁed by calculating the relative risk
with a 95% conﬁdence interval. Later, a stepwise multivariate
logistic regression analysis was performed to determine the inde-
pendent predictive factors associated with CI and delirium, and
those predictingmortality and functional decline in PPs with CI and
delirium. Values of p< 0.05 were considered signiﬁcant. Calcula-
tions were done using SPSS version 16.0 software.
3. Results
A total of 1632 PPs were included (53% male, mean age:
77.9 9.8 years). In 1434 of these, cognitive status was assessed by
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Fig. 2. Number of patients with wrong answers on the SPMSQ in a multicenter sample
of Spanish PPs. Question 1: What are the date, month, and year?; Question 2: What is
the day of the week?; Question 3: What is the name of this place?; Question 4: What is
your phone number?; Question 5: How old are you?; Question 6: When were you
born?; Question 7: Who is the current president?; Question 8: Who was the president
before him?; Question 9: What was your mother’s maiden name?; Question 10: Can
you count backward from 20 by 3s? PP¼ polypathological patient; SPMSQ¼ Short
Portable Mental Status Questionnaire.
L. Moreno-Gaviño et al.86means of SPMSQ (the remaining 198 had CAM criteria of concurrent
delirium at inclusion interview). The median number of errors on
the baseline SPMSQ was 2 (IQR¼ 5). CI was present in 39% of the
PPs [28% of themmild to moderate (3e7 errors), and 11% severe (
8 errors)] (Fig. 1). The questions that were most frequently
answered wrongly were the simple mathematical calculations
(50%, question number 10), temporal orientation (35% and 23.4%,
questions 1 and 2, respectively), and references to recent socio-
familial issues (25% and 32%, questions 7 and 8, respectively)
(Fig. 2). The main clinical and care features of PPs with CI are
detailed in Table 1. Additionally, only 147 (26.3%) of PPs with CI
were previously diagnosed with established dementia; 74% were at
risk or had already established sociofamilial problems; and 46.7%
and 90.2% were functionally dependent in performing ADLs and
IAs, respectively.
The factors independently associated with CI were advanced age
[p< 0.0001; RR¼ 1.035 (1.018e1.052)], female sex [p< 0.0001;
RR¼ 1.9 (1.4e2.5)], chronic neurological diseases as an inclusion
category [p< 0.0001; RR¼ 2.7 (2e3.6)], low bodymass index (BMI)
[p¼ 0.015; RR¼ 1.03 (1.006e1.051)], use of neuroleptics [p¼ 0.013;
RR¼ 1.9 (1.15e3.3)], functional impairment for IAs [p< 0.0001;
RR¼ 1.18 (1.05e1.26)], and sociofamilial frailty [p< 0.0001;
RR¼ 1.09 (1.04e1.14)].
One-year mortality among the PPs who completed the follow-
up period [1338 (93.3%) of the 1434 included] was 46% in those
with CI, and 31.4% in those without CI [p< .00001; RR¼ 1.8
(1.5e2.3)]. Mean survival after inclusion was 305 4 days in PPs
with CI compared with 266 5 days in those without CI
(p< 0.0001) (Fig. 3). Functional decline with respect to basal status,
in PPs who survived (10-point, 20-point, and 30-point falls in
performing ADLs, by means of BI), was similar in PPs with CI (this
occurred in 66%, 55%, and 44% of them, respectively), compared to
those without CI (62%, 53%, and 46%, respectively). Factors inde-
pendently associated with mortality in PPs with CI were the pres-
ence of a concomitant active neoplasm [p¼ 0.007; RR¼ 3
(1.3e6.7)], severe dyspnea (at least NYHA/MRC class III) [p¼ 0.04;
RR¼ 1.6 (1.02e2.6)], higher comorbidity load measured by
Charlson Index [p¼ 0.003; RR¼ 1.2 (1.07e1.4)], and  4 hospital
admissions in the previous 12 months [p< 0.0001; RR¼ 5.2
(2.4e11.5)].
The prevalence of delirium during the most recent hospital stay
was 11% (n¼ 198). Women represented 54%, with a median age of0
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Fig. 1. Severity of CI in a multicenter sample of Spanish PPs, according to number of
errors on the SPMSQ. 0e2 errors: no CI; 3e7 errors: mildemoderate CI; 8e10 errors:
severe CI. CI¼ cognitive impairment; PP¼ polypathological patient; SPMSQ¼ Short
Portable Mental Status Questionnaire.79 9 years, median inclusion categories 2.8 0.8, and other
comorbidities 2.91.8, a basal BI of 47.5 35 points, and an asso-
ciated comorbidity weight on the Charlson Index of 4 2 points.
Dementia had been previously diagnosed in 50% of the cases. The
variables predictive of deliriumwere female sex [p¼ 0.038, RR¼ 1.6
(1.025e2.48)], higher dependence for IAs on the LB index
[p¼ 0.041, RR¼ 1.16 (1.34e2.48)], previous diagnosis of dementia
[p¼ 0.017, RR¼ 1.95 (1.12e3.4)], high comorbidity load on the
Charlson Index [p¼ 0.028, RR¼ 1.11 (1.011e1.22)], low BMI
[p¼ 0.037, RR¼ 1.04 (1.002e1.08)], and the presence of hypo-
albuminemia [p¼ 0.025, RR¼ 1.7 (1.07e2.8)]. One-year mortality
among PPs with delirium at inclusion was 54.5% [34.8% in PPs
without delirium, p< 0.0001, RR¼ 2.25 (1.65e3)]. Mean survival
after inclusion was 296 4 days in PPs with delirium compared
with 24110 days in those without delirium (p< 0.0001) (Fig. 4).
Factors independently associated with mortality in PPs with
delirium at inclusion were age  85 years [p¼ 0.021, RR¼ 2.3
(1.14e4.6)], chronic liver disease [p¼ 0.019, RR¼ 5.9 (1.3e25)],
severe dyspnea (at least NYHA/MRC class III) [p¼ 0.007; RR¼ 2.7
(1.3e5.4)], plasma creatinine levels > 2 mg/dL [p¼ 0.003; RR¼ 7.8
(2e26)], and polypharmacy [p¼ 0.0019; RR¼ 3.1 (1.2e8.1)].
4. Discussion
We detected a high prevalence of CI in a hospital-based multi-
center cohort of PPs. These rates were similar to those described in
PPs in a primary care setting, and higher than those detected in
hospitalized adults over the age of 65 years2,21,22. Despite this
prevalence of CI, only 26% of PPs were diagnosed with established
dementia and about half of those with CI did not present with
symptoms of any chronic neurological disease. This suggests a clear
trend to underdiagnose CI in PPs when no systematic evaluation is
performed. This trend has already been noted in hospitalized adults
over 70 years old, but at lower rates than those detected in the PP
cohort in our study23.
Among the conditions associated with CI in PPs, advanced age is
a risk factor that is often described in. Chronic neurological disease
as an inclusion category is another risk factor for CI in PPs. This
category refers to any neurological disease (e.g., dementia or
Parkinson’s disease) in which signiﬁcant cognitive impairment
already exists ( 5 errors on the Pfeiffer Scale), but also to those
neurological diseases that have signiﬁcant functional repercus-
sions, implying the individual’s loss of autonomy, and cerebral
vascular disease; it is well known that all these conditions increase
risk of developing CI by 4e12 times (23). The association between
Fig. 3. One-year survival of a multicentric population of PPs in Spain with or without
CI, by means of KaplaneMeier curve. CI¼ cognitive impairment; PP¼ polypathological
patient.
Fig. 4. One-year survival of a multicentric population of PPs of Spain with or without
delirium in their last hospital admission, by means of Kaplan-Meier curve. PP¼
polypathological patient.
Table 1
Comparison of main clinical and care features of a Spanish multicenter sample of PPs with and without CI (bivariate analysis).
Clinical features [mean SD/median (IQR)/N (%)] CI (n¼ 559) No CI (n¼ 875) [p value if <0.05; RR (95% conﬁdence interval)]
Age (y) 79.88.5 74.7 9.8 (p< 0.0001)
Sex (male/female) 43%/57% 62%/38% [p< 0.0001; RR 2.2 (1.7e2.7)]
Requiring caregiver 73.8% 32.6% [p< 0.0001; RR 5.8 (4.6e7.4)]
Number of deﬁning categories/patient 2.65 0.8 2.68 0.88
Patients with  3 categories 47.5% 48%
Prevalence of PP deﬁning categories
Category A (heart diseases) 73.6% 81.3% [p¼ 0.001; RR 0.64 (0.5e0.82)]
Category C (lung diseases) 52% 40% [p< 0.0001; RR 0.6 (0.5e0.76)]
Category E (neurological diseases) 53% 22.7% [p< 0.0001; RR 3.8 (3e4.8)]
Category B (kidney/autoimmune diseases) 31.8% 34.2%
Category G (chronic neoplasia/anaemia) 27%) 23%
Category F (peripheral arterial disease/diabetes with neuropathy) 26.7% 21% [p¼ 0.014; RR 0.7 (0.56e0.9)]
Category H (degenerative osteoarticular disease) 21.6% 13.1% [p< 0.0001; RR 1.8 (1.4e2.4)]
Category D (liver disease) 8% 4.3% [p¼ 0.006; RR 0.5 (0.3e0.8)]
Number of other comorbidities/ patient 2.92 1.7 3.05 1.8
Patients with  4 other comorbidities 33.1 % 36.5%
Most frequent other comorbidities
Hypertension 74% 71.4%
Arrhythmias 37.3% 36.8%
Atrial ﬁbrillation 36% 34.9%
Other arrhythmias 1.3% 1.9%
Diabetes without visceral involvement 32.6% 27.8%
Dyslipidemia 31% 26.6%
Anxiety and depressive disorders 12.6% 15.2%
Charlson Index /Charlson Index adjusted by age 4 [2]/7 [2] 3 [3]/7 [3]
Mean plasma creatinine (mg/dL)/hemoglobin (g/dL) 1.32 18/11.36 2.8 1.32 0.8/11.4 2.9
Albumin (g/dL)/BMI 3.2 [0.6]/28 6 3.4 [0.6] (p< 0.0001)/29 7 (p¼ 0.012)
Patients with > 1 fall in past 12 mo 18.2% 13.4% [p¼ 0.01; RR 1.44 (1.07e1.9)]
Patients with active neoplasia at inclusion 10.4% 11.8%
Hospitalizations in past 12 mo 1.78 1.6 1.96 1.7 (p¼ 0.048)
Basal BI 57.2 33 81.7 23 (p< 0.0001)
Basal LB Index F¼ 1 [3]; M¼ 1 [3] F¼ 4 [4]; M¼ 4 [5] (p< 0.0001)
Gijon’s sociofamilial risk scale 11.7 3.2 9.6 3.1 (p< 0.0001)
Number of prescribed drugs/patients with polypharmacy 7.85 3.4/84% 8 3.2/87%
Patients with psychoactive drugs 38.7% 27.5% [p< 0.0001; RR 1.7 (1.3e2.1)]
Benzodiazepines 23.6% 21%
Antidepressants 16.2% 10.7% [p¼ 0.002; RR 1.6 (1.2e2.2)]
Neuroleptics 12.1% 3.2% [p< 0.0001; RR 4.1 (2.6e6.6)]
BI¼ Barthel Index; BMI¼ body mass index; CI¼ cognitive impairment; F¼ female; IQR¼ interquartile range; LB¼ LawtoneBrody; M¼male; PP¼ polypathological patient;
RR¼ Relative risk; SD¼ standard deviation.
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L. Moreno-Gaviño et al.88CI and low BMI as well as functional impairment in performing IAs
were other relevant ﬁndings of our study, and are a consequence
more than a factor of CI in most PPs; once established, malnutrition
and functional impairment become themselves ominous factors of
poor health results and perceived quality of life24e27. The detected
sociofamilial frailty in PPs with CI is narrowly correlated with most
previous associated factors, and reﬂects the deep impact of having
to care for a dependent PPwith CI in informal caregivers, family and
close social environment28. Finally, the use of neuroleptics was
associated with CI. This ﬁnding can be explained by the use of these
drugs for neuropsychiatricebehavioral symptoms in patients with
CI and dementia, but also because neuroleptics themselves can
generate cognitive and motor impairment. Moreover, the anticho-
linergic effect of neuroleptics can worsen memory deﬁcits in
patients with dementia. Nevertheless, cognitive function is not only
affected by age, or by pathologies like dementia, but is also affected
to some degree, be it acute or chronic, by different processes, such
as: anemia, cancer, respiratory failure, and other diseases. Many
of these processes are PP deﬁning inclusion categories. Moreover,
this CI can be a reﬂection of the impact that polypathology has on
the overall functioning of an individual, making it clear that all
levels of health care and assistance should be appropriate and
coordinated29,30.
The management and treatment of PPs is more difﬁcult when CI
is present. It is crucial to evaluate them in order to make decisions,
elaborate advanced therapeutic plans, and determine assistance
and therapeutic objectives. The high prevalence of polypharmacy in
PPs is added to this fact, and as we saw in this study, this prevalence
is also present in PPs with CI31. This makes the role of the personal
care assistant indispensable, and as we know, one of the factors
associated with higher perceived load by PP personal care assis-
tants is CI28. This complicates the scene for correct pharmaceutical
use and therapeutic conciliation in PPs with CI; in this sense, we
believe one of the keys for improvement should pivot around an
emphatic and trusting relationship between healthcare workers
and the patientepersonal care assistant partnership32e34.
One of the most relevant ﬁndings of our study was the higher
mortality rates of PPs with CI compared with those without CI,
which was evident even during ﬁrst 2 months of follow-up. These
results are in agreement with previous reports, which have iden-
tiﬁed CI as a potent prognostic factor. Recent data also support that
death risk is maximal during the ﬁrst year after diagnosis of
dementia24,35. CI and other chronic neurological conditions are also
factors of notable weight in predicting 1-year functional decline of
PPs36. All of these clinical, care and prognostic implications make
necessary the systematic evaluation of cognitive function in PPs, to
plan best treatment and care choices.
Delirium at last hospital admission was present in 11% of the
recruited PPs. This rate is in the low range of rates obtained in most
studies based on elderly hospitalized patients (6e56%)12. This can
be explained because, although the cohort is homogeneous with
respect to clinical characteristics, 25% of the PPs in the cohort were
attending outpatient clinics or undergoing home hospitalization,
and therefore, were not exposed to a precipitating factor for
delirium, such as hospitalization. In our series, therewas a previous
diagnosis of dementia in half of the cases. The presence of delirium
was independently associated with age, female sex, higher
comorbidity, higher dependence for IAs, dementia, malnutrition
measured by low BMI, and hypoalbuminemia. Among these factors,
age, dementia, functional impairment and comorbidity are pre-
disposing factors for delirium and they are part of a predictive
model for the development of delirium. Malnutrition has also been
identiﬁed as a predicting factor for delirium37. Contrary to our
study, male sex was classically described as a predisposing factor
for developing delirium. PPs with delirium also presented witha higher mortality rate, which was also evident during the ﬁrst 2
months of follow-up, which is concordant with recent data that
confer the development and persistence of delirium as an impor-
tant factor of short-term (6 months) mortality38,39.
Our study was not free of limitations. A substantial weakness
could be the diagnostic criteria of CI, for which there are no stan-
dardized diagnostic criteria, unlike dementia and delirium, which
are well deﬁned by the DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition) international classiﬁcation.
The absence of universal diagnostic criteria underlies the variability
of prevalence in different studies, because different tests have been
used. In our study, CI was evaluated exclusively with the SPMSQ
because of its universality; other instruments were not applied
[Petersen criteria, Euro-Test (Money test), Memory Alteration Test,
or biomarkers, functional, or image tests] because of their relatively
less extension for clinical use, and/or because they have not been
validated in Spain. This could potentially reduce data accuracy, but
we think this was not the case, because SPMSQ has been exten-
sively validated in different Spanish populations.
In conclusion, CI and delirium are common in PPs. CI was
detected frequently in patients who did not present with symptoms
of chronic neurological disease, suggesting that it is underdiagnosed
when no systematic evaluation is carried out. Both conditions play
a notable deleterious role in 12-month survival. A systematic
cognitive assessment as well as prevention and early detection of
delirium should be included in the clinical care of all PPs.
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